INTRODUCTION
============

Osteoid osteomas (OOs) represent approximately 10% of benign bone tumors and were first identified as a separate entity by Jaffe \[[@hnx042-B1]\]. OOs are most commonly found in the femur, the tibia and the spine, but can be found throughout the body \[[@hnx042-B2]\]. Approximately 1--3% of OOs are localized to the pelvic region \[[@hnx042-B3], [@hnx042-B4]\] and approximately 20% of all OOs are located in the proximal femur \[[@hnx042-B5]\]. Five to 12% of OOs have an intra-articular location \[[@hnx042-B1]\], and approximately 13% of intra-articular osteoid osteoma (IAOO) lesions occur at the hip joint \[[@hnx042-B6]\]. While IAOO at the hip is a relatively rare diagnosis, its presentation can mimic many other hip pathologies, so is an important entity to keep in the differential diagnosis.

The typical presentation of an extra-articular OO is severe pain, often including night pain in 80% of patients \[[@hnx042-B2]\], which is relieved with administration of aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) \[[@hnx042-B7]\]. The proximal femur, along with the proximal humerus, the proximal radius and the distal fibula, is unique in that the metaphysis is partially intracapsular. It has been reported that IAOOs can present with atypical symptoms, but there has not been a clear consensus on the hip IAOOs presentation. Hip IAOOs have been reported as presenting with synovitis, joint effusion, decreased ROM, muscle atrophy in the affected leg or abductor muscles \[[@hnx042-B8]\], limb length discrepancy \[[@hnx042-B3]\] or even hip contractures \[[@hnx042-B9]\]. In the acetabular OO lesions specifically, patients have presented with chronic pain \[[@hnx042-B10]\], chronic synovitis \[[@hnx042-B9], [@hnx042-B11]\], normal hip mobility \[[@hnx042-B10]\] and partial pain relief with NSAIDs \[[@hnx042-B10]\]. Hip IAOOs have also been associated with growth disturbances of the hip \[[@hnx042-B12]\], rapid development of osteoarthritis (OA) \[[@hnx042-B13]\], severe radicular pain, progressive and diffuse muscular atrophy and weakness in the affected limb, and diminished deep tendon reflexes \[[@hnx042-B14], [@hnx042-B15]\]. These sometimes subtle and non-specific presentations can be a diagnostic challenge. The lag in diagnosis of patients with general IAOO has been reported to be up to three times longer (26.6 months) than those with more classic extra-articular lesions (8.5 months) \[[@hnx042-B6]\].

Treatment of OO can be non-surgical. Prolonged administration of oral salicylates and NSAIDs has been reported to take 2--15 years for the OO pain to resolve \[[@hnx042-B16]\]. Surgical treatment of OO lesions in the acetabulum has included open surgical hip dislocation \[[@hnx042-B9]\], percutaneous radiofrequency ablation (RFA), hip arthroscopy \[[@hnx042-B17]\], the use of an intra-articular laser with en block excision \[[@hnx042-B18]\], burring the lesion \[[@hnx042-B17], [@hnx042-B19]\] or using a curette to excise the lesion \[[@hnx042-B20]\], arthroscopically assisted RFA \[[@hnx042-B21]\], or intraoperative percutaneous RFA \[[@hnx042-B22]\]. Surgical treatment of femoral neck OOs has included excision with the arthroscopic burr and electrosurgical instruments \[[@hnx042-B11], [@hnx042-B19]\], a modified core decompression technique \[[@hnx042-B8]\], excisional biopsy or intralesional curettage through an anterior hip approach \[[@hnx042-B23]\], with internal fixation or cast immobilization \[[@hnx042-B23]\], and a lateral approach and en bloc excision through the greater trochanter \[[@hnx042-B24]\]. The standard treatment most often reported for acetabular OOs has been an open surgical procedure to access the cartilage surface \[[@hnx042-B25], [@hnx042-B26]\]. RFA is also commonly used to treat OOs in all locations, and has a reported overall success rate of up to 90% in permanently treating OOs \[[@hnx042-B10], [@hnx042-B27]\]. However, complications of RFA include infections, skin burns, bleeding, nerve injury, tendonitis or thrombosis. There has also been a report of long-term (10 years) femur fracture after RFA of a proximal femur lesion \[[@hnx042-B28]\], and mid-term (1 year after procedure) symptomatic articular damage has been reported after treatment with RFA \[[@hnx042-B10]\]. RFA is contraindicated when in close proximity to the spinal cord or peripheral nerves adjacent to disrupted cortical bone \[[@hnx042-B10]\]. If the entire lesion is not ablated with RFA, recurrence can occur \[[@hnx042-B29]\].

While multiple case reports have described IAOOs in the acetabulum \[[@hnx042-B9], [@hnx042-B10], [@hnx042-B17], [@hnx042-B19], [@hnx042-B30]\] and femoral neck \[[@hnx042-B11], [@hnx042-B12], [@hnx042-B19], [@hnx042-B23], [@hnx042-B30], [@hnx042-B33], [@hnx042-B37], [@hnx042-B45]\], as well as the femoral head \[[@hnx042-B35], [@hnx042-B50], [@hnx042-B51]\] ([Table I](#hnx042-T1){ref-type="table"}), we report the largest case series of OOs of the intra-articular region of the hip treated with hip arthroscopy. We share limited pre- and post-surgical outcome scores after treatment with hip arthroscopy. We also discuss the presentation (symptom location and duration) and imaging findings in patients with IAOO of the hip. Table I.Review of the literature---previous reports of IAOO of the hipCitationYearNumber of patients with hip IAOOAge/ average ageLocation of lesionTreatmentFollow-up (months)Outcome scores?Agrawal *et al.* \[[@hnx042-B14]\]2009111Proximal femoral shaftNRNRNoAhlfeld *et al.* \[[@hnx042-B23]\]1990515Femoral neckOpen excision48NoAlvarez *et al.* \[[@hnx042-B18]\]2001116AcetabulumArthroscopy1NoAsik *et al.* \[[@hnx042-B20]\]201417AcetabulumArthroscopy +RFA8NoBanga *et al.* \[[@hnx042-B52]\]2014152Femoral neckNon-op7NoBarnhard *et al.* \[[@hnx042-B31]\]2011120AcetabulumArthroscopyNRNoBettelli *et al.* \[[@hnx042-B3]\]19892NRAcetabulumOpen excision37NoBosschaert *et al.* \[[@hnx042-B10]\]2010117AcetabulumRFA12NoCallaghan *et al.* \[[@hnx042-B25]\]19986Five acetabulum, 1 femoral neckOpen excisionNRNoCarter *et al.* \[[@hnx042-B8]\]1990117Femoral neckOpen excision24NoCassar-Pullicino *et al.* \[[@hnx042-B56]\]1992223Femoral neck, acetabulumOpen excision36NoChang *et al.* \[[@hnx042-B32]\]2010129AcetabulumArthroscopy12Node los Santos *et al.* \[[@hnx042-B26]\]2013112AcetabulumOpen excision36NoDunlap *et al.* \[[@hnx042-B50]\]1985114Aemoral headNon-opNRNoFoeldvari *et al.* \[[@hnx042-B13]\]1998114Femoral neckOpen excision5NoGille *et al.* \[[@hnx042-B9]\]1990214AcetabulumOpen excision3NoGiustra *et al.* \[[@hnx042-B12]\]1970214One femoral neck, 1 proximal femoral shaftOpen excisionNRNoGoldberg *et al.* \[[@hnx042-B33]\]197531NR (range 2-16)Femoral neck, acetabulumTwenty-nine open excision, 2 non-opNRNoHerget *et al.* \[[@hnx042-B11]\]2012121Femoral neckArthroscopyNRNoKang *et al.* \[[@hnx042-B61]\]2014124Femoral neckCT-guided excision43NoKarray *et al.* \[[@hnx042-B44]\]2010116AcetabulumOpen excisionNRNoKattapuram *et al.* \[[@hnx042-B54]\]198311NRSeven femoral neck, 2 acetabulum, 2 NRNRNRNoKhapchik *et al.* \[[@hnx042-B19]\]2001226One acetabulum, 1 femoral neckArthroscopy21NoLee *et al.* \[[@hnx042-B34]\]2009211One acetabulum, 1 femoral neckArthroscopy19NoMarwan *et al.* \[[@hnx042-B17]\]2015131AcetabulumArthroscopy44NoMuscolo *et al.* \[[@hnx042-B35]\]1994419Three femoral neck, 1 femoral headCT-guided excision27NoNehme *et al.* \[[@hnx042-B30]\]2012227One femoral neck, 1 acetabulumArthroscopy24NoNinomiya *et al.* \[[@hnx042-B36]\]1989212One acetabulum, 1 femoral headOpen excision14 and NRNoPapagelopoulos *et al.* \[[@hnx042-B37]\]200616NREight femoral head, 6 femoral neck, 2 acetabulumRFA30NoParlier-Cuau *et al.* \[[@hnx042-B38]\]1999320AcetabulumCT-guided excision36NoPianta *et al.* \[[@hnx042-B46]\]2012116Femoral neckRFA12NoRaux *et al.* \[[@hnx042-B47]\]201426NRFemoral neckCT-guided excisionNRNoRaux *et al.* \[[@hnx042-B39]\]2013517AcetabulumCT-guided excision18NoRicci *et al.* \[[@hnx042-B21]\]2013147AcetabulumArthroscopy + RFA22NoRichardson *et al.* \[[@hnx042-B48]\]2009118Femoral neckCT-guided excisionNRNoScalici *et al.* \[[@hnx042-B51]\]2011124Femoral headOpen excision60NoSestan *et al.* \[[@hnx042-B49]\]2005111Femoral neckNon-op60NoShoji *et al.* \[[@hnx042-B40]\]2014112AcetabulumArthroscopy16NoSzendroi *et al.* \[[@hnx042-B6]\]2004920Three acetabulum, 6 femoral neckTwo open excision, 7 curettage29NoTamam *et al.* \[[@hnx042-B41]\]2014123AcetabulumArthroscopyNRNoTokis *et al.* \[[@hnx042-B29]\]2013119AcetabulumArthroscopy12NoTsuruomto *et al.* \[[@hnx042-B42]\]2005115AcetabulumOpen excision96NoXiao *et al.* \[[@hnx042-B62]\]201119Femoral neckOpen excision12No

MATERIALS AND METHODS
=====================

Study population
----------------

We retrospectively identified all patients in our institution's hip preservation group who had been given a diagnosis of OO of the hip (acetabulum or intra-articular proximal femur). We reviewed available radiographic, computed tomography (CT) and magnetic resonance imaging (MRI) of the lesions to describe lesion location. We excluded any patient who did not have a confirmed diagnosis of OO (either biopsy confirmed or definitive diagnosis made from either CT or MRI imaging by a fellowship trained musculoskeletal radiologist. If MRI was not pathognomonic and CT was not available, we excluded the patient).

Of these patients, we further selected those who were enrolled in our institutional review board--approved hip registry of prospectively collected data on over 1800 procedures in 1600 patients since 2010. Patients are enrolled after providing informed consent, and data collected include pre-, intra-, and post-operative findings, patient-reported outcomes pre- and post-operatively, and radiographic reports. From these patients, we were able to analyse patient-reported outcome scores.

Outcome measures
----------------

Patient-reported outcome scores were tabulated when available. The hip registry includes scores for the modified Harris Hip Score (mHHS), the international Hip Outcomes Tool (iHot33), the Hip Outcome Score-Activity of Daily Living (HOS-ADL) and the Hip Outcome Score--Sport-Specific Subscale (HOS-SSS). These scores are routinely obtained pre-operatively, at 6 months, 1 year and yearly thereafter through final follow-up.

Statistical analysis
--------------------

Descriptive statistics were reported in terms of means and standard deviations for continuous demographic variables, and in terms of total number and percentage of patients for discrete variables. Descriptive statistics were similarly reported for clinical characteristics in terms of total number of procedures. Paired *t*-tests were used to compare the latest post-operative scores at 6 months or greater to pre-operative scores. Frequency and percentage of patients achieving a minimal clinically important difference for arthroscopic treatment of femoroacetabular impingement (FAI) were calculated.

A comparison group of all patients undergoing hip arthroscopy for isolated cam- or rim-impingement was included for demographic and baseline outcome score comparison in a non-matched case--control design. These included unilateral or bilateral scopes between 10 July 2007 and 14 April 2016 with completed survey scores at baseline.

All analyses were conducted using SAS version 9.3 (SAS Inc., Cary, NC, USA).

RESULTS
=======

Forty patients from the hip preservation group database were identified as having a hip IAOO between 2000 and 2015. Ten lesions were located in the acetabulum, 29 in the femoral neck and 1 in the femoral head. Twenty-four patients were male and 16 female, with the average age of 24.5 years (range 11--57).

Thirty of the 40 patients underwent intervention for their OO at our institution. Ten patients were either lost to follow-up or were treated non-operatively ([Table II](#hnx042-T2){ref-type="table"}). Of those who sought treatment, 16 underwent RFA, 13 underwent hip arthroscopy and 1 underwent open excision. Of the patients who were treated with RFA, 13 of the lesions were located in the femoral neck and 3 in the acetabulum. Of the patients treated with hip arthroscopy, nine lesions were in the femoral neck, three were in the acetabulum and one was in the inferior femoral head. The one patient who underwent open excision had a lesion in the acetabulum. Of the 13 patients who had arthroscopic excision of the OO, the concomitant arthroscopic procedures performed were as follows: 8 had labral repair, 7 had rim decompression, 9 had cam decompression, 1 had subspine decompression, 2 had iliopsoas release and 4 had labral debridement. All 13 patients who underwent arthroscopic excision of the OO had the lesion confirmed by pathology. Table II.Treatment course of patients who did not undergo treatment at our institution (10 of 40 patients)Patients treated non-operatively or lost to follow-upNumber of patientsInitiated PT---lost to follow-up3Lost to follow-up2Pain level manageable---patient opted for conservative management1Recommended RFA---patient refused1Recommended arthroscopy---patient refused1Recommended RFA---lost to follow-up1Intra-articular injection + initiated PT ---lost to follow-up1

The main presenting symptom for each patient was documented ([Table III](#hnx042-T3){ref-type="table"}). The duration of symptoms at the time of initial evaluation at our institution was also noted ([Table IV](#hnx042-T4){ref-type="table"}), as was the prevalence of night pain and pain relief with NSAIDs ([Table V](#hnx042-T5){ref-type="table"}). Table III.Main presenting symptoms of patients with confirmed IAOO of the hipMain presenting symptomNumber of patients% of patientsGroin pain923Anterior hip pain615Groin pain w/anterior hip pain410Lateral hip pain410Generalized hip pain410Groin pain w/radiation to leg13Groin pain w/lateral hip pain13Groin pain w/anterior and posterior hip pain13Groin pain w/anterior and lateral hip pain13Buttock pain w/radiation to groin and leg13Anterior hip pain w/posterior pain13Pelvic pain13Not recorded615Table IV.Duration of symptoms upon initial evaluation at our institutionDuration of symptomsNumber of patients% of patients0--6 months10256 months to 1 year9231--2 years615\>2 years820Not recorded718Table V.Presence of night pain and pain relief with NSAIDsPresence of night painNumber of patients% of patientsNight pain1538No night pain38Not recorded2255*Pain relief with NSAIDsNumber of patients% of patients*Pain relief with NSAIDs2358No pain relief with NSAIDs1025Not recorded1333

We reviewed the CT imaging available on our IAOO patients (13 of 40). The average alpha angle in these patients was 64.6° ($\pm \,$13.1°), coronal center edge angle 30.2° ($\pm \,$3.8°), femoral neck shaft angle 133.2° ($\pm$4.9°), acetabular version at 1 o'clock 3° ($\pm \,$6.9°), 2 o'clock 8.8° ($\pm \,$8.3°) and 3 o'clock 16° ($\pm \,$5.4°). On MRI review, 65% (26 of 40) of the patients had edema surrounding the OO lesions.

Of the 13 patients treated with hip arthroscopy, 5 had both pre- and post-operative mHHS and HOS-ADL. Four had both pre- and post-op iHot33 scores, and three had both pre- and post-op HOS-SSS scores. The mean pre-op mHHS in these patients was 58.1, HOS-ADL 65.3, HOS-SSS 41.7, iHot33 37.5. At final follow-up, the mean scores were mHHS 93.9 (Δ35.9, *P* = 0.002), HOS-ADL 98.2 (Δ33.0, *P* = 0.006), HOS-SSS 90.7 (Δ49.1, *P* = 0.06) and iHot33 80.0 (Δ42.5, *P* = 0.006). We had no reported surgical complications and no recurrences of the lesion at the time of last follow-up (average 27 months, range 3--105 months).

A comparison group of all patients undergoing hip arthroscopy for isolated cam- or rim-impingement was included. There were no statistically significant differences in gender or age between these groups ([Table VI](#hnx042-T6){ref-type="table"}), nor were there any statistically significant differences between baseline pre-operative scores (mHHS, HOS-ADL, HOS-SSS and iHot33) ([Table VII](#hnx042-T7){ref-type="table"}). Given the small number of hip IAOO patients with post-operative outcome scores, we were not able to directly compare post-operative scores between our study group and the group of FAI patients undergoing hip arthroscopy. Table VI.Demographic comparison of patients undergoing hip arthroscopy for FAI only and patients undergoing hip arthroscopy with IAOO in a non-matched case--control designPatients with IAOOPatients with FAI only*N*%*N*%Odds ratios (95% CI)*P*-valueTotal number of patients14153Female642.910669.30.3 (0.1 to 1.0)0.39Bilateral321.41610.52.3 (0.6 to 9.3)0.14Revision17.195.91.2 (0.1 to 10.5)0.39*MeanSDMeanSDDifference in means (95% CI)P*-*value*Age (years)23.78.429.210.65 (--6 to 10)0.064Table VII.Comparison of preoperative scores for patients undergoing hip arthroscopy for FAI only and patients undergoing hip arthroscopy for IAOOPreoperative survey score (*N*= \# IAOO, *N* = \# FAI)Patients with IAOO (*N* = 14)Patients with FAI only (*N* = 153)Unadjusted difference (95% CI)*P*-valueAdjusted difference^a^ (95% CI)*P*-valuemHHS (mean ± SD)62156013−2 (−9 to 7)0.631 (−6 to 9)0.70(*N* = 13, *N* = 153)HOS ADL (mean ± SD)74217217−1 (−13 to 10)0.801 (−9 to 11)0.77(*N* = 13, *N* = 153)HOS Sport (mean ± SD)61244924−12 (−26 to 1)0.099−6 (−21 to 8)0.40(*N* = 11, *N* = 153)iHot33 (mean ± SD)41243819−3 (−17 to 11)0.645 (−7 to 18)0.41(*N* = 9, *N* = 153)[^1]

DISCUSSION
==========

IAOO of the hip may be a confounding diagnosis in patients presenting with hip pain and symptoms consistent with FAI. Diagnosis of this rare but treatable benign bone tumor is often delayed due to its atypical presentation \[[@hnx042-B6]\], and based on our findings, its similarity with symptomatic presentation of FAI. Case reports in the literature have previously reported of the coexistence of OO and FAI \[[@hnx042-B52]\] and described multiple treatment options, including hip arthroscopy \[[@hnx042-B11], [@hnx042-B17], [@hnx042-B19]\]. We report the largest case series of hip IAOO treated with hip arthroscopy (13 patients), and discuss the clinical presentation of a total of 40 patients with confirmed diagnosis of IAOO of the hip.

Males are more commonly affected by OO than females, at a rate of 2:1 \[[@hnx042-B2]\] to 3:1 \[[@hnx042-B27]\]. In our series of hip IAOO, 24 patients were male and 16 were female, a male to female ratio of 1.5:1. The location of the IAOO lesions was on both sides of the hip joint; however, there was almost a 3:1 ratio of lesions in the femoral neck compared with the acetabulum (29 IAOO in the femoral neck, 10 IAOO in the acetabulum and 1 in the inferior femoral head). OO with intra-articular location has been reported to present with atypical and varied symptoms, different from the classic night pain relieved by NSAIDs found with extra-articular OO \[[@hnx042-B3], [@hnx042-B8]\]. Our patients had a wide range of presentations consistent with previous reports of IAOO, but the most common presenting symptom was groin pain ([Table III](#hnx042-T3){ref-type="table"}). Groin pain is also the most common presenting symptom of FAI \[[@hnx042-B53]\]. This overlap in symptoms of IAOO and more common causes of hip pathology, such as FAI, can be part of the reason IAOO of the hip is misdiagnosed or missed. Previous reports have emphasized the delay in diagnosis of OO of the proximal femur, which have been reported to range between 12 months and 2 years after pain onset \[[@hnx042-B23]\]. In our series, patients presented with a more evenly distributed duration of symptoms between acute, sub-acute and chronic ([Table IV](#hnx042-T4){ref-type="table"}).

Radiographic features of hip IAOO may differ from extra-articular lesions. The IAOO may not be evident on plain radiograph ([Figs 1A and 4A](#hnx042-F1){ref-type="fig"}), as the nidus of OO is not visible on plain radiographs until the lesion is greater than 4 mm in size \[[@hnx042-B54]\]. Additionally, in a majority of subchondral or subperiosteal intra-articular lesions, there is no surrounding sclerosis on plain radiograph \[[@hnx042-B6]\]. CT is the gold standard for diagnosing OO \[[@hnx042-B23]\] as it is the most useful imaging modality to identify the OO nidus \[[@hnx042-B6]\], which classically appears as a central calcification and surrounding sclerosis ([Figs 1F and 4C](#hnx042-F1){ref-type="fig"}). When the OO is near a joint, CT may demonstrate changes on both sides of the joint, including osteophyte formation, a localized soft-tissue mass, reduced bone density or increased bone density in the subchondral bone of the abutting joint surface \[[@hnx042-B55]\]. Additional intra-articular imaging findings include joint effusion ([Fig. 3](#hnx042-F3){ref-type="fig"}), periarticular osteoporosis and periosteal reaction \[[@hnx042-B54]\]. Varying amounts of tumor mineralization may be present, with more calcification often correlated with more mature lesions \[[@hnx042-B56]\]. While lesions located in the bone cortex may present with large periosteal reaction, the lack of adjacent periosteum in intra-articular lesions often results in only a mild osteoblastic response \[[@hnx042-B56]\].

![The radiographic imaging of one patient in our series with IAOO of the hip who presented with left groin pain. (**A**) AP pelvis. (**B**) Lateral radiograph demonstrates loss of femoral head neck offset with a small cortical irregularity at the head-neck junction. (**C**) 3D CT scan demonstrates large cam lesion. (**D**) MRI demonstrates superior labral tear. (**E**) MRI shows OO lesion. (**F**) CT shows characteristic appearance of OO.](hnx042f1){#hnx042-F1}

MRI appearance of OO is often more aggressive than the lesion actually is, with extensive bone marrow edema and even adjacent soft tissue signal changes can be seen \[[@hnx042-B56], [@hnx042-B57]\] ([Figs 2](#hnx042-F2){ref-type="fig"}, [3](#hnx042-F3){ref-type="fig"} and [4B](#hnx042-F4){ref-type="fig"}). MRI can demonstrate variable signal intensity and juxta-lesional edema of the OO depending on the amount of calcification present, the vascularity and age of the lesion \[[@hnx042-B58]\]. Chondral hypertrophy has also been described with intra-articular hip OO lesions \[[@hnx042-B56]\], which could be identified on MRI. Sixty-five percent of the MRI reports in our series (26 of 40) describe significant edema. This is consistent with previous findings, where 63% of OOs on MRI (12 of 19) showed perinidal bone marrow edema and inflammation \[[@hnx042-B59]\]. While MRI is often the imaging modality used to assess hip and groin pain, the diagnostic accuracy of MRI in detecting OO is not as reliable as with CT \[[@hnx042-B58], [@hnx042-B59]\]. MRI fails to identify 21% of intra-articular OOs and only poorly identifies them in an additional 29% \[[@hnx042-B58]\].

![(**A**) Coronal STIR MRI demonstrating edema of the right acetabulum surrounding the OO lesion. (**B**) Coronal CT demonstrating OO lesion (arrow). (**C**) Axial T2 FSE fat saturated MRI again demonstrating bone marrow edema. (**D**) Axial CT of OO (arrow).](hnx042f2){#hnx042-F2}

![(**A**) STIR coronal MRI demonstrating bone marrow edema of the left femoral neck surrounding the OO lesion and left hip joint effusion. (**B**) T2 Axial MRI fat-saturated sequence demonstrating OO (arrow) at left anteromedial femoral neck.](hnx042f3){#hnx042-F3}

![(**A**) Pre-operative AP Pelvis of a left inferior femoral neck IAOO. (**B**) Pre-operative MRI demonstrating significant edema in the femoral neck surrounding the OO lesion. (**C**) Pre-operative CT scan of characteristic CT findings of OO, demonstrating a nidus with surrounding sclerotic bone.](hnx042f4){#hnx042-F4}

Multiple treatment options exist for treatment of symptomatic OO, including open excision, RFA or arthroscopic excision. The gold standard treatment for OO in all locations is RFA \[[@hnx042-B10], [@hnx042-B27]\]. Patients in our series were referred RFA if the lesion was a safe distance from the articular cartilage, and they had no evidence of other intra-articular pathology that could be addressed with hip arthroscopy.

The decision to proceed with arthroscopic excision of the hip IAOO in our patient population was based on (i) lesion accessibility with hip arthroscopy instrumentation, (ii) the presence of additional pathology which could be addressed with hip arthroscopy and (iii) in depth discussion with the patient about available options and the patient's treatment preference.

Marwan *et al.* \[[@hnx042-B17]\] recently published a systematic review of all acetabular IAOO treated with hip arthroscopy. From this review of 11 cases, they reported a success rate of greater than 90% in treating acetabular OOs with hip arthroscopy and noted no recurrences of the lesion at last follow-up ranging between 6 months and 2 years, and one study not reporting follow-up duration \[[@hnx042-B17]\]. Similarly, in our case series, none of our patients treated with hip arthroscopy had recurrence of the lesion after our treatment at an average 27-months follow-up (range 3--105 months). There were, however, three patients who presented to our institution after previous intervention for their IAOO, and at the time of our initial evaluation, had either persistent or recurrent IAOO. All three patients had previously undergone RFA: one patient proceeded with no further treatment, another patient underwent subsequent hip arthroscopy and the third patient had a repeat CT-guided RFA.

Norman *et al.* \[[@hnx042-B60]\] looked at a series of 182 OOs over 24 years and found 30 of which were intra-articular at the hip joint. Of these 30 lesions, 50% were associated with the development of OA \[[@hnx042-B60]\]. Rapid development of OA has also been described as beginning as early as 5 months after OO lesion excision \[[@hnx042-B13]\]. None of our patients with IAOO had concomitant diagnoses of OA; however, we would require longer and more complete follow-up to determine the incidence of degenerative changes related to the IAOO. This strong correlation of OA with IAOO does, however, give us incentive to identify these lesions early, and treat symptomatic IAOO more aggressively to prevent the theoretical sequela of early hip OA.

There have been multiple case reports and a number of case series of hip IAOO ([Table I](#hnx042-T1){ref-type="table"}). Our case series is the largest of hip IAOO of the hip treated by hip arthroscopy ([Fig. 5](#hnx042-F5){ref-type="fig"}). While we had a very small number of patients who had both pre- and post-operative outcome scores after treatment with hip arthroscopy, this is the first report of patient-reported outcomes in this subset of patients. We noted a significant improvement in mHHS, HOS-ADL and iHot33 scores. Our comparison group of patients ([Tables VI and VII](#hnx042-T6){ref-type="table"}), included patients undergoing hip arthroscopy for FAI only, as this was the closest group of patients to a control group who had taken the pre-operative patient-reported outcome surveys. The FAI only and IAOO patients were matched in age, gender and unilaterality/bilaterality of surgery as well as revision status. When comparing baseline, pre-operative patient-reported outcome scores, the FAI-only hip arthroscopy patient scores were not statistically different from the scores of those patients with hip IAOO undergoing hip arthroscopy. This emphasizes that patients with hip IAOO can present almost identically to patients with FAI. The physician should be extra vigilant to keep the diagnosis of hip IAOO in the differential.

![In this left hip with femoral neck OO, intraoperative radiographic image demonstrating the contour of the femoral head-neck junction prior to (**A**) and after (**B**) CAM decompression and OO excision. Intraoperative arthroscopic image showing OO of the femoral neck prior to (**C, D**), during (**E**) and after (**F**) excision with a curette an arthroscopic burr.](hnx042f5){#hnx042-F5}

Limitations
-----------

Given that the diagnosis of IAOO is relatively rare, we have limited numbers of patients who had this diagnosis and were treated with hip arthroscopy. This case series includes only a small number of patients who had long-term follow-up. We excluded patients who had OA, although it is possible that older patients who had advanced OA once had an OO, especially given the high incidence of OA associated with hip IAOO \[[@hnx042-B60]\]. If IAOO was in the differential based on hip MRI, but the patient did not have a confirmatory CT scan, they were also excluded. Given the limitations of MRI to definitively identify OO \[[@hnx042-B58]\], it is possible we missed OO lesions that would have been present on CT scan if the patient had undergone CT. While all excised IAOO were confirmed by histology, we did not obtain post-operative CT to evaluate the lesion (as this practice is not standard of care). Additionally, many of our patients had multiple procedures in addition to the arthroscopic excision and ablation of the IAOO. This does confound the post-surgical PROs, as there is no way to delineate what benefit the patients received from IAOO excision versus treatment of other intra-articular pathology. Another significant limitation to this study was that we did not have patient-reported outcome scores or long-term follow-up on those patients who underwent RFA, as our registry only collects data on post-operative patients and those that follow for non-operative treatment of hip pain. Those patients who underwent RFA had post-procedure follow-up outside of our practice. A comparison between patients who underwent IAOO with RFA versus hip arthroscopy would be clinically useful, but in our series patients were indicated for hip arthroscopy over the gold standard RFA if they met a number of criteria. We favored hip arthroscopy in patients who had a lesion close to the articular cartilage where there was concern for the potential detrimental effects of RFA to the cartilage; or if they had concomitant intra-pathology that could be addressed with hip arthroscopy.

CONCLUSIONS
===========

Our series presents 13 patients with IAOO of the hip treated with hip arthroscopy and the clinical presentation of 40 patients with confirmed diagnosis of hip IAOO. While OO in the intra-articular hip location is a relatively rare diagnosis, our findings highlight the importance of keeping IAOO in the differential diagnosis of patients with hip pain. If an IAOO is diagnosed in the hip joint, we propose the following treatment algorithm: If there is no coexistence of FAI or other intra-articular pathology, RFA remains a viable option with a proven success rate if the lesion is far enough away from the articular cartilage to minimize concern for cartilaginous injury. If FAI or intra-articular pathology is also present, RFA of the IAOO with a staged treatment of the FAI is also an option, especially if it is unclear which pathology is the predominant etiology of the patient's symptoms. If the OO is in the setting of, or exacerbating, symptomatic FAI, we believe that hip arthroscopy is the preferred treatment method to address all of the patient's hip pathology during one intervention, and has the added benefit of obtaining tissue for a definitive diagnosis of the OO lesion.
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